BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kenny RG, Marmion CJ. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens? Chem Rev 2019;119:1058-137. [PMID: 30640441 DOI: 10.1021/acs.chemrev.8b00271] [Cited by in Crossref: 220] [Cited by in F6Publishing: 172] [Article Influence: 73.3] [Reference Citation Analysis]
Number Citing Articles
1 Steel TR, Walsh F, Wieczorek-błauż A, Hanif M, Hartinger CG. Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents. Coordination Chemistry Reviews 2021;439:213890. [DOI: 10.1016/j.ccr.2021.213890] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
2 Claudel M, Schwarte JV, Fromm KM. New Antimicrobial Strategies Based on Metal Complexes. Chemistry 2020;2:849-99. [DOI: 10.3390/chemistry2040056] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
3 Marković K, Milačič R, Marković S, Kladnik J, Turel I, Ščančar J. Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS. Molecules 2020;25:E1512. [PMID: 32225069 DOI: 10.3390/molecules25071512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gupta PSS, Bhat HR, Biswal S, Rana MK. Computer-aided discovery of bis-indole derivatives as multi-target drugs against cancer and bacterial infections: DFT, docking, virtual screening, and molecular dynamics studies. Journal of Molecular Liquids 2020;320:114375. [DOI: 10.1016/j.molliq.2020.114375] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bai X, Ali A, Wang N, Liu Z, Lv Z, Zhang Z, Zhao X, Hao H, Zhang Y, Rahman FU. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies. Eur J Med Chem 2022;227:113920. [PMID: 34742012 DOI: 10.1016/j.ejmech.2021.113920] [Reference Citation Analysis]
6 Sousa LM, Araújo DMS, Oliveira KM, De Oliveira LP, Maia PIS, Deflon VM, Batista AA, Machado AEH, Guerra W, Von Poelhsitz G. Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands. Journal of Coordination Chemistry 2020;73:1605-18. [DOI: 10.1080/00958972.2020.1777286] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhang Z, Yang T, Zhang J, Li W, Li S, Sun H, Liang H, Yang F. Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy. J Med Chem 2022. [PMID: 35324188 DOI: 10.1021/acs.jmedchem.1c01790] [Reference Citation Analysis]
8 Papadia P, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1R,2R and 1S,2S enantiomers of the trans-1,2-diamino-4-cyclohexene ligand (DACHEX), an analogue of diaminocyclohexane used in oxaliplatin. Dalton Trans 2021;50:15655-68. [PMID: 34673864 DOI: 10.1039/d1dt02255e] [Reference Citation Analysis]
9 Kacsir I, Sipos A, Ujlaki G, Buglyó P, Somsák L, Bai P, Bokor É. Ruthenium Half-Sandwich Type Complexes with Bidentate Monosaccharide Ligands Show Antineoplastic Activity in Ovarian Cancer Cell Models through Reactive Oxygen Species Production. Int J Mol Sci 2021;22:10454. [PMID: 34638791 DOI: 10.3390/ijms221910454] [Reference Citation Analysis]
10 Haseloer A, Lützenburg T, Strache JP, Neudörfl J, Neundorf I, Klein A. Building up PtII -Thiosemicarbazone-Lysine-sC18 Conjugates. Chembiochem 2021;22:694-704. [PMID: 32909347 DOI: 10.1002/cbic.202000564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Backman-Blanco G, Valdés H, Ramírez-Apan MT, Cano-Sanchez P, Hernandez-Ortega S, Orjuela AL, Alí-Torres J, Flores-Gaspar A, Reyes-Martínez R, Morales-Morales D. Synthesis of Pt(II) complexes of the type [Pt(1,10-phenanthroline)(SArFn)2] (SArFn = SC6H3-3,4-F2; SC6F4-4-H; SC6F5). Preliminary evaluation of their in vitro anticancer activity. J Inorg Biochem 2020;211:111206. [PMID: 32801098 DOI: 10.1016/j.jinorgbio.2020.111206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Liu C, Li C, Jiang S, Zhang C, Tian Y. pH-responsive hollow Fe–gallic acid coordination polymer for multimodal synergistic-therapy and MRI of cancer. Nanoscale Adv 2021;4:173-81. [DOI: 10.1039/d1na00721a] [Reference Citation Analysis]
13 Oliveira KM, Peterson EJ, Carroccia MC, Cominetti MR, Deflon VM, Farrell NP, Batista AA, Correa RS. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. Dalton Trans 2020;49:16193-203. [PMID: 32329497 DOI: 10.1039/d0dt01091j] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
14 Cai DH, Zhang CL, Liu QY, He L, Liu YJ, Xiong YH, Le XY. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate. Eur J Med Chem 2021;213:113182. [PMID: 33486198 DOI: 10.1016/j.ejmech.2021.113182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Maji M, Acharya S, Maji S, Purkait K, Gupta A, Mukherjee A. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand. Inorg Chem 2020;59:10262-74. [PMID: 32585099 DOI: 10.1021/acs.inorgchem.0c01433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Timerbaev AR. Application of ICP-MS to the development of metal-based drugs and diagnostic agents: where do we stand? J Anal At Spectrom 2021;36:254-66. [DOI: 10.1039/d0ja00404a] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang Y, Ma D, Sun J, Song C, Huo S. Reduction of an asymmetric Pt(IV) prodrug fac-[Pt(dach)Cl3(OC(=O)CH3)] by biological thiol compounds: kinetic and mechanistic characterizations. Transit Met Chem 2021;46:623-31. [DOI: 10.1007/s11243-021-00480-6] [Reference Citation Analysis]
18 Du Y, Wang H, Zhang T, Wen W, Li Z, Bi M, Liu J. An ESIPT-based fluorescent probe with fast-response for detection of hydrogen sulfide in mitochondria. Spectrochim Acta A Mol Biomol Spectrosc 2022;265:120390. [PMID: 34536889 DOI: 10.1016/j.saa.2021.120390] [Reference Citation Analysis]
19 Hassoon AA, Szorcsik A, Bogár F, Papp IZ, Fülöp L, Kele Z, Gajda T. The interaction of half-sandwich (η5-Cp*)Rh(III) cation with histidine containing peptides and their ternary species with (N,N) bidentate ligands. J Inorg Biochem 2021;216:111330. [PMID: 33360738 DOI: 10.1016/j.jinorgbio.2020.111330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Upadhyay A, Kumar Jha R, Batabyal M, Dutta T, Koner AL, Kumar S. Janus -faced oxidant and antioxidant profiles of organo diselenides. Dalton Trans 2021;50:14576-94. [PMID: 34590653 DOI: 10.1039/d1dt01565f] [Reference Citation Analysis]
21 Shutkov IA, Okulova YN, Tyurin VY, Sokolova EV, Babkov DA, Spasov AA, Gracheva YA, Schmidt C, Kirsanov KI, Shtil AA, Redkozubova OM, Shevtsova EF, Milaeva ER, Ott I, Nazarov AA. Ru(III) Complexes with Lonidamine-Modified Ligands. Int J Mol Sci 2021;22:13468. [PMID: 34948263 DOI: 10.3390/ijms222413468] [Reference Citation Analysis]
22 Łakomska I, Śmiłowicz D, Jakubowski M, Sitkowski J, Wojtczak A. Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents. Materials (Basel) 2020;13:E5312. [PMID: 33255252 DOI: 10.3390/ma13235312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Jain S, Bhar K, Bandyopadhayaya S, Singh VK, Mandal CC, Tapryal S, Sharma AK. Development, evaluation and effect of anionic co-ligand on the biological activity of benzothiazole derived copper(II) complexes. J Inorg Biochem 2020;210:111174. [PMID: 32652261 DOI: 10.1016/j.jinorgbio.2020.111174] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jayawardhana AMDS, Stilgenbauer M, Datta P, Qiu Z, Mckenzie S, Wang H, Bowers D, Kurokawa M, Zheng YR. Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36. Chem Commun (Camb) 2020;56:10706-9. [PMID: 32789350 DOI: 10.1039/d0cc02174a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chakraborty A, Roy S, Chakraborty MP, Roy SS, Purkait K, Koley TS, Das R, Acharya M, Mukherjee A. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation. Inorg Chem 2021;60:18379-94. [PMID: 34780170 DOI: 10.1021/acs.inorgchem.1c02979] [Reference Citation Analysis]
26 Kumar P, Singh P, Saren S, Pakira S, Sivakumar S, Patra AK. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity. Dalton Trans 2021;50:8196-217. [PMID: 34031678 DOI: 10.1039/d1dt00246e] [Reference Citation Analysis]
27 Liu Z, Li Z, Du T, Chen Y, Wang Q, Li G, Liu M, Zhang N, Li D, Han J. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism. Dalton Trans 2021;50:362-75. [PMID: 33319888 DOI: 10.1039/d0dt03194a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Holden L, Burke CS, Cullinane D, Keyes TE. Strategies to promote permeation and vectorization, and reduce cytotoxicity of metal complex luminophores for bioimaging and intracellular sensing. RSC Chem Biol 2021;2:1021-49. [PMID: 34458823 DOI: 10.1039/d1cb00049g] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Lai L, Xiong Z, Ma L, Chen T. Smart Microenvironment-Responsive Organocopper(II) Supramolecular Polymers to Regulate the Stability and Anticancer Efficacy by Different Substituents. ACS Appl Mater Interfaces 2020;12:40013-20. [PMID: 32805979 DOI: 10.1021/acsami.0c09919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Biancalana L, Kostrhunova H, Batchelor LK, Hadiji M, Degano I, Pampaloni G, Zacchini S, Dyson PJ, Brabec V, Marchetti F. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity. Inorg Chem 2021;60:9529-41. [PMID: 34156246 DOI: 10.1021/acs.inorgchem.1c00641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? J Med Chem 2021;64:11364-78. [PMID: 34342437 DOI: 10.1021/acs.jmedchem.1c00706] [Reference Citation Analysis]
32 Xiong K, Qian C, Yuan Y, Wei L, Liao X, He L, Rees TW, Chen Y, Wan J, Ji L, Chao H. Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II. Angew Chem Int Ed Engl 2020;59:16631-7. [PMID: 32533618 DOI: 10.1002/anie.202006089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
33 Păunescu E, Boubaker G, Desiatkina O, Anghel N, Amdouni Y, Hemphill A, Furrer J. The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties. Eur J Med Chem 2021;222:113610. [PMID: 34144354 DOI: 10.1016/j.ejmech.2021.113610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Saini B, Singh R, Mukhopadhyay S, Mukherjee TK. Specific Loading and In Vitro Controlled Release of a Ru-Based Hydrophobically Encapsulated Model Anticancer Drug inside Nanoassemblies toward Stimuli-Responsive Drug Delivery. ACS Appl Nano Mater 2021;4:2037-51. [DOI: 10.1021/acsanm.0c03356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
35 He M, Chen F, Shao D, Weis P, Wei Z, Sun W. Photoresponsive metallopolymer nanoparticles for cancer theranostics. Biomaterials 2021;275:120915. [PMID: 34102525 DOI: 10.1016/j.biomaterials.2021.120915] [Reference Citation Analysis]
36 Xian C, Chen H, Xiong F, Fang Y, Huang H, Wu J. Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs. Biomater Sci 2021. [PMID: 34323260 DOI: 10.1039/d1bm00879j] [Reference Citation Analysis]
37 Das D, Raza MK, Goswami TK. Evaluation of photochemotherapeutic potential of a few oxo-bridged dimeric Fe(III) compounds having Salen-type ligands. Polyhedron 2020;186:114614. [DOI: 10.1016/j.poly.2020.114614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Karges J, Chao H, Gasser G. Synthesis, Characterization, and Biological Evaluation of the Polymeric Encapsulation of a Ruthenium(II) Polypyridine Complex with Pluronic F‐127/Poloxamer‐407 for Photodynamic Therapy Applications. Eur J Inorg Chem 2020;2020:3242-8. [DOI: 10.1002/ejic.202000545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Nagy S, Ozsváth A, Bényei AC, Farkas E, Buglyó P. Donor Atom Preference of Organoruthenium and Organorhodium Cations on the Interaction with Novel Ambidentate (N,N) and (O,O) Chelating Ligands in Aqueous Solution. Molecules 2021;26:3586. [PMID: 34208223 DOI: 10.3390/molecules26123586] [Reference Citation Analysis]
40 Ferraro MG, Piccolo M, Misso G, Santamaria R, Irace C. Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics. Pharmaceutics 2022;14:954. [DOI: 10.3390/pharmaceutics14050954] [Reference Citation Analysis]
41 Mandal P, Sonkar C, Dhankhar SS, Nagaraja C, Mukhopadhyay S. Ruthenium(II)-arene complexes containing ferrocenamide ligands: Synthesis, characterisation and antiproliferative activity against cancer cell lines. Journal of Organometallic Chemistry 2020;916:121247. [DOI: 10.1016/j.jorganchem.2020.121247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Khoury A, Sakoff JA, Gilbert J, Scott KF, Karan S, Gordon CP, Aldrich-wright JR. Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity. Pharmaceutics 2022;14:787. [DOI: 10.3390/pharmaceutics14040787] [Reference Citation Analysis]
43 Deo KM, Sakoff J, Gilbert J, Zhang Y, Aldrich Wright JR. Synthesis, characterisation and influence of lipophilicity on cellular accumulation and cytotoxicity of unconventional platinum(iv) prodrugs as potent anticancer agents. Dalton Trans 2019;48:17228-40. [PMID: 31728483 DOI: 10.1039/c9dt04049h] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
44 Santi M, Mapanao AK, Biancalana L, Marchetti F, Voliani V. Ruthenium arene complexes in the treatment of 3D models of head and neck squamous cell carcinomas. Eur J Med Chem 2021;212:113143. [PMID: 33445155 DOI: 10.1016/j.ejmech.2020.113143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Das B, Gupta P. Luminescent terpyridine appended geminal bisazide and bistriazoles: multinuclear Pt(II) complexes and AIPE-based DNA detection with the naked eye. Dalton Trans 2021;50:10225-36. [PMID: 34236066 DOI: 10.1039/d1dt01108a] [Reference Citation Analysis]
46 Paul S, Kundu P, Kondaiah P, Chakravarty AR. BODIPY-Ruthenium(II) Bis-Terpyridine Complexes for Cellular Imaging and Type-I/-II Photodynamic Therapy. Inorg Chem 2021;60:16178-93. [PMID: 34672556 DOI: 10.1021/acs.inorgchem.1c01850] [Reference Citation Analysis]
47 Frei A, Zuegg J, Elliott AG, Baker M, Braese S, Brown C, Chen F, G Dowson C, Dujardin G, Jung N, King AP, Mansour AM, Massi M, Moat J, Mohamed HA, Renfrew AK, Rutledge PJ, Sadler PJ, Todd MH, Willans CE, Wilson JJ, Cooper MA, Blaskovich MAT. Metal complexes as a promising source for new antibiotics. Chem Sci 2020;11:2627-39. [PMID: 32206266 DOI: 10.1039/c9sc06460e] [Cited by in Crossref: 86] [Cited by in F6Publishing: 29] [Article Influence: 43.0] [Reference Citation Analysis]
48 Jayawardhana AMDS, Zheng YR. Interactions between mitochondria-damaging platinum(IV) prodrugs and cytochrome c. Dalton Trans 2022;51:2012-8. [PMID: 35029256 DOI: 10.1039/d1dt03875c] [Reference Citation Analysis]
49 Cao Q, Zhou D, Pan Z, Yang G, Zhang H, Ji L, Mao Z. CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors. Angew Chem 2020;132:18715-21. [DOI: 10.1002/ange.202005362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
50 Zhao X, Ji H, Hasrat K, Misal S, He F, Dai Y, Ma F, Qi Z. A mitochondria-targeted single fluorescence probe for separately and continuously visualizing H2S and Cys with multi-response signals. Analytica Chimica Acta 2020;1107:172-82. [DOI: 10.1016/j.aca.2020.02.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
51 Biancalana L, Batchelor LK, Pereira SAP, Tseng P, Zacchini S, Pampaloni G, Saraiva LMFS, Dyson PJ, Marchetti F. Bis‐conjugation of Bioactive Molecules to Cisplatin‐like Complexes through (2,2′‐Bipyridine)‐4,4′‐Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen. Chem Eur J 2020;26:17525-35. [DOI: 10.1002/chem.202003199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chen L, Wu X, Gilchrist AM, Gale PA. Organoplatinum Compounds as Anion‐Tuneable Uphill Hydroxide Transporters. Angewandte Chemie. [DOI: 10.1002/ange.202116355] [Reference Citation Analysis]
53 Bhattacharyya A, Jameei A, Saha R, Garai A, Karande AA, Chakravarty AR. BODIPY-linked cis -dichlorido zinc( ii ) conjugates: the strategic design of organelle-specific next-generation theranostic photosensitizers. Dalton Trans 2021;50:103-15. [DOI: 10.1039/d0dt03342a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Li C, Xu F, Zhao Y, Zheng W, Zeng W, Luo Q, Wang Z, Wu K, Du J, Wang F. Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity. Front Chem 2020;8:210. [PMID: 32411653 DOI: 10.3389/fchem.2020.00210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
55 Swaminathan S, Haribabu J, Kalagatur NK, Konakanchi R, Balakrishnan N, Bhuvanesh N, Karvembu R. Synthesis and Anticancer Activity of [RuCl26-arene)(aroylthiourea)] Complexes-High Activity against the Human Neuroblastoma (IMR-32) Cancer Cell Line. ACS Omega 2019;4:6245-56. [PMID: 31459766 DOI: 10.1021/acsomega.9b00349] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
56 Michlewska S, Kubczak M, Maroto-Díaz M, Sanz Del Olmo N, Ortega P, Shcharbin D, Gomez Ramirez R, Javier de la Mata F, Ionov M, Bryszewska M. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug. Biomolecules 2019;9:E411. [PMID: 31450702 DOI: 10.3390/biom9090411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
57 Annunziata A, Liberti D, Bedini E, Cucciolito ME, Loreto D, Monti DM, Merlino A, Ruffo F. Square-Planar vs. Trigonal Bipyramidal Geometry in Pt(II) Complexes Containing Triazole-Based Glucose Ligands as Potential Anticancer Agents. Int J Mol Sci 2021;22:8704. [PMID: 34445409 DOI: 10.3390/ijms22168704] [Reference Citation Analysis]
58 Liang X, Li L, Tang J, Komiyama M, Ariga K. Dynamism of Supramolecular DNA/RNA Nanoarchitectonics: From Interlocked Structures to Molecular Machines. BCSJ 2020;93:581-603. [DOI: 10.1246/bcsj.20200012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 17.0] [Reference Citation Analysis]
59 Tong KKH, Hanif M, Lovett JH, Hummitzsch K, Harris HH, Söhnel T, Jamieson SMF, Hartinger CG. Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity. Molecules 2020;25:E3661. [PMID: 32796732 DOI: 10.3390/molecules25163661] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
60 Liu X, Shao M, Liang C, Guo J, Wang G, Yuan XA, Jing Z, Tian L, Liu Z. Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups. Chembiochem 2021;22:557-64. [PMID: 32964620 DOI: 10.1002/cbic.202000511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Zhang Z, Yu P, Gou Y, Zhang J, Li S, Cai M, Sun H, Yang F, Liang H. Novel Brain-Tumor-Inhibiting Copper(II) Compound Based on a Human Serum Albumin (HSA)-Cell Penetrating Peptide Conjugate. J Med Chem 2019;62:10630-44. [DOI: 10.1021/acs.jmedchem.9b00939] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
62 Yempala T, Babu T, Karmakar S, Nemirovski A, Ishan M, Gandin V, Gibson D. Expanding the Arsenal of Pt IV Anticancer Agents: Multi‐action Pt IV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group. Angew Chem 2019;131:18386-91. [DOI: 10.1002/ange.201910014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 Maji M, Karmakar S, Ruturaj, Gupta A, Mukherjee A. Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancer. Dalton Trans 2020;49:2547-58. [PMID: 32022814 DOI: 10.1039/c9dt04269e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
64 Rubio AR, González R, Busto N, Vaquero M, Iglesias AL, Jalón FA, Espino G, Rodríguez AM, García B, Manzano BR. Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal. Pharmaceutics 2021;13:1540. [PMID: 34683834 DOI: 10.3390/pharmaceutics13101540] [Reference Citation Analysis]
65 Bai X, Ali A, Lv Z, Wang N, Zhao X, Hao H, Zhang Y, Rahman FU. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. Eur J Med Chem 2021;224:113689. [PMID: 34293698 DOI: 10.1016/j.ejmech.2021.113689] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Sen S, Won M, Levine MS, Noh Y, Sedgwick AC, Kim JS, Sessler JL, Arambula JF. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Chem Soc Rev 2022. [PMID: 35099487 DOI: 10.1039/d1cs00417d] [Reference Citation Analysis]
67 Purkait K, Ruturaj, Mukherjee A, Gupta A. ATP7B Binds Ruthenium(II) p-Cymene Half-Sandwich Complexes: Role of Steric Hindrance and Ru-I Coordination in Rescuing the Sequestration. Inorg Chem 2019;58:15659-70. [PMID: 31657924 DOI: 10.1021/acs.inorgchem.9b02780] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
68 Swaminathan S, Haribabu J, Mohamed Subarkhan MK, Gayathri D, Balakrishnan N, Bhuvanesh N, Echeverria C, Karvembu R. Impact of aliphatic acyl and aromatic thioamide substituents on the anticancer activity of Ru(II)-p-cymene complexes with acylthiourea ligands-in vitro and in vivo studies. Dalton Trans 2021;50:16311-25. [PMID: 34730582 DOI: 10.1039/d1dt02611a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Yempala T, Babu T, Karmakar S, Nemirovski A, Ishan M, Gandin V, Gibson D. Expanding the Arsenal of PtIV Anticancer Agents: Multi-action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group. Angew Chem Int Ed Engl 2019;58:18218-23. [PMID: 31599054 DOI: 10.1002/anie.201910014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
70 Frei A, King AP, Lowe GJ, Cain AK, Short FL, Dinh H, Elliott AG, Zuegg J, Wilson JJ, Blaskovich MAT. Nontoxic Cobalt(III) Schiff Base Complexes with Broad-Spectrum Antifungal Activity. Chemistry 2021;27:2021-9. [PMID: 33231906 DOI: 10.1002/chem.202003545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Manzano CM, Nakahata DH, de Paiva RE. Revisiting metallodrugs for the treatment of skin cancers. Coordination Chemistry Reviews 2022;462:214506. [DOI: 10.1016/j.ccr.2022.214506] [Reference Citation Analysis]
72 Sánchez-mora A, Valdés H, Ramírez-apan MT, Nieto-camacho A, Hernández-ortega S, Canseco-gonzález D, Morales-morales D. NHC-Ir(I) complexes derived from 5,6-dinitrobenzimidazole. Synthesis, characterization and preliminary evaluation of their in vitro anticancer activity. Inorganica Chimica Acta 2019;496:119061. [DOI: 10.1016/j.ica.2019.119061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
73 Purkait K, Mukherjee A. Cytotoxicity and reactivity of a redox active 1,4-quinone-pyrazole compound and its Ru(II)-p-cymene complex. Inorganica Chimica Acta 2020;502:119361. [DOI: 10.1016/j.ica.2019.119361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
74 Nahaei A, Mandegani Z, Chamyani S, Fereidoonnezhad M, Shahsavari HR, Kuznetsov NY, Nabavizadeh SM. Half-Sandwich Cyclometalated RhIII Complexes Bearing Thiolate Ligands: Biomolecular Interactions and In Vitro and In Vivo Evaluations. Inorg Chem 2022. [PMID: 35023727 DOI: 10.1021/acs.inorgchem.1c03218] [Reference Citation Analysis]
75 Fronik P, Poetsch I, Kastner A, Mendrina T, Hager S, Hohenwallner K, Schueffl H, Herndler-Brandstetter D, Koellensperger G, Rampler E, Kopecka J, Riganti C, Berger W, Keppler BK, Heffeter P, Kowol CR. Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands. J Med Chem 2021;64:12132-51. [PMID: 34403254 DOI: 10.1021/acs.jmedchem.1c00770] [Reference Citation Analysis]
76 Ma YC, Tang XF, Xu YC, Jiang W, Xin YJ, Zhao W, He X, Lu LG, Zhan MX. Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy via DNA damage enhancement. Biomater Sci 2021;9:3401-9. [PMID: 33949448 DOI: 10.1039/d1bm00157d] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Pragti, Kundu BK, Mukhopadhyay S. Target based chemotherapeutic advancement of ruthenium complexes. Coordination Chemistry Reviews 2021;448:214169. [DOI: 10.1016/j.ccr.2021.214169] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Zhang S, Wang X, Guo Z. Rational design of anticancer platinum(IV) prodrugs. Medicinal Chemistry. Elsevier; 2020. pp. 149-82. [DOI: 10.1016/bs.adioch.2019.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Ding Y, Dai Y, Wu M, Li L. Glutathione-mediated nanomedicines for cancer diagnosis and therapy. Chemical Engineering Journal 2021;426:128880. [DOI: 10.1016/j.cej.2021.128880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
80 Frei A. Metal Complexes, an Untapped Source of Antibiotic Potential? Antibiotics (Basel) 2020;9:E90. [PMID: 32085590 DOI: 10.3390/antibiotics9020090] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 17.5] [Reference Citation Analysis]
81 Barrett S, De Franco M, Kellett A, Dempsey E, Marzano C, Erxleben A, Gandin V, Montagner D. Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes. J Biol Inorg Chem 2020;25:49-60. [DOI: 10.1007/s00775-019-01732-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
82 Kar B, Das U, De S, Pete S, Sharma S A, Roy N, S K AK, Panda D, Paira P. GSH-resistant and highly cytoselective ruthenium(II)-p-cymene-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agents. Dalton Trans 2021;50:10369-73. [PMID: 34308466 DOI: 10.1039/d1dt01604k] [Reference Citation Analysis]
83 Yu H, Tan Y, Kuang D, Zhang F, Jiang W. Synthesis, structure and biological activity of diphenyltin complexes based on O,N,O-tridentate ligands. Inorganica Chimica Acta 2019;496:119044. [DOI: 10.1016/j.ica.2019.119044] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
84 Zhang R, Song XQ, Liu RP, Ma ZY, Xu JY. Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. J Med Chem 2019;62:4543-54. [PMID: 31002510 DOI: 10.1021/acs.jmedchem.9b00128] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
85 Zhang Q, Wang S, Zhu Y, Zhang C, Cao H, Ma W, Tian X, Wu J, Zhou H, Tian Y. Functional Platinum(II) Complexes with Four-Photon Absorption Activity, Lysosome Specificity, and Precise Cancer Therapy. Inorg Chem 2021;60:2362-71. [PMID: 33494602 DOI: 10.1021/acs.inorgchem.0c03245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
86 Lázaro A, Balcells C, Quirante J, Badia J, Baldomà L, Ward JS, Rissanen K, Font-Bardia M, Rodríguez L, Crespo M, Cascante M. Luminescent PtII and PtIV Platinacycles with Anticancer Activity Against Multiplatinum-Resistant Metastatic CRC and CRPC Cell Models. Chemistry 2020;26:1947-52. [PMID: 31909511 DOI: 10.1002/chem.201905325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
87 Saha S, Peña B, Dunbar KR. Partially Solvated Dinuclear Ruthenium Compounds Bridged by Quinoxaline-Functionalized Ligands as Ru(II) Photocage Architectures for Low-Energy Light Absorption. Inorg Chem 2019;58:14568-76. [PMID: 31647230 DOI: 10.1021/acs.inorgchem.9b02232] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
88 Kaur M, Loveleen, Kumar R. Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes. Bioorg Chem 2020;105:104396. [PMID: 33130345 DOI: 10.1016/j.bioorg.2020.104396] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Bouché M, Hognon C, Grandemange S, Monari A, Gros PC. Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites. Dalton Trans 2020;49:11451-66. [PMID: 32776052 DOI: 10.1039/d0dt02135k] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Priyanka Dorairaj D, Haribabu J, Chang Y, C. N. Hsu S, Echeverria C, Echeverria J, Karvembu R. Effect of new Pd(II)-aroylthiourea complex on pancreatic cancer cells. Inorganic Chemistry Communications 2021;134:109018. [DOI: 10.1016/j.inoche.2021.109018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Jiang C, Huang H, Kang X, Yang L, Xi Z, Sun H, Pluth MD, Yi L. NBD-based synthetic probes for sensing small molecules and proteins: design, sensing mechanisms and biological applications. Chem Soc Rev 2021;50:7436-95. [PMID: 34075930 DOI: 10.1039/d0cs01096k] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Štarha P, Trávníček Z. Non-platinum complexes containing releasable biologically active ligands. Coordination Chemistry Reviews 2019;395:130-45. [DOI: 10.1016/j.ccr.2019.06.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 10.7] [Reference Citation Analysis]
93 Guarra F, Pratesi A, Gabbiani C, Biver T. A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes. J Inorg Biochem 2021;217:111355. [PMID: 33596529 DOI: 10.1016/j.jinorgbio.2021.111355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
94 Ramu V, Gautam S, Kondaiah P, Chakravarty AR. Diplatinum(II) Catecholate of Photoactive Boron-Dipyrromethene for Lysosome-Targeted Photodynamic Therapy in Red Light. Inorg Chem 2019;58:9067-75. [PMID: 31268715 DOI: 10.1021/acs.inorgchem.9b00567] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
95 Swaminathan S, Haribabu J, Kalagatur NK, Nikhil M, Balakrishnan N, Bhuvanesh NSP, Kadirvelu K, Kolandaivel P, Karvembu R. Tunable Anticancer Activity of Furoylthiourea-Based RuII -Arene Complexes and Their Mechanism of Action. Chemistry 2021;27:7418-33. [PMID: 33404126 DOI: 10.1002/chem.202004954] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
96 Peña Q, Wang A, Zaremba O, Shi Y, Scheeren HW, Metselaar JM, Kiessling F, Pallares RM, Wuttke S, Lammers T. Metallodrugs in cancer nanomedicine. Chem Soc Rev 2022. [PMID: 35262108 DOI: 10.1039/d1cs00468a] [Reference Citation Analysis]
97 Cuccioloni M, Bonfili L, Cecarini V, Nabissi M, Pettinari R, Marchetti F, Petrelli R, Cappellacci L, Angeletti M, Eleuteri AM. Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene Complexes. ChemMedChem 2020;15:105-13. [PMID: 31701643 DOI: 10.1002/cmdc.201900551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Mojaddami A, Karimi A, Mahdavinia M, Fereidoonnezhad M. Antiproliferative activity and DNA binding studies of cyclometalated complexes of platinum(II) containing 2-vinylpyridine. Biometals 2022. [PMID: 35445906 DOI: 10.1007/s10534-022-00392-7] [Reference Citation Analysis]
99 Tang L, Cai D, Qin M, Lu S, Hu MH, Ruan S, Jin G, Wang Z. Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy. ACS Omega 2020;5:726-34. [PMID: 31956823 DOI: 10.1021/acsomega.9b03381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
100 Cao Q, Zhou DJ, Pan ZY, Yang GG, Zhang H, Ji LN, Mao ZW. CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors. Angew Chem Int Ed Engl 2020;59:18556-62. [PMID: 32557982 DOI: 10.1002/anie.202005362] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
101 Zhang WY, Banerjee S, Imberti C, Clarkson GJ, Wang Q, Zhong Q, Young LS, Romero-Canelón I, Zeng M, Habtemariam A, Sadler PJ. Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry. Inorganica Chim Acta 2020;503:119396. [PMID: 33776131 DOI: 10.1016/j.ica.2019.119396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
102 Moynihan E, Bassi G, Ruffini A, Panseri S, Montesi M, Velasco-Torrijos T, Montagner D. Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma. Front Chem 2021;9:795997. [PMID: 34950638 DOI: 10.3389/fchem.2021.795997] [Reference Citation Analysis]
103 Balsa LM, Rodriguez MR, Parajón-Costa BS, González-Baró AC, Lavecchia MJ, León IE. Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres. ChemMedChem 2021. [PMID: 34750978 DOI: 10.1002/cmdc.202100520] [Reference Citation Analysis]
104 Karmakar J, Nandy P, Das S, Bhattacharya D, Karmakar P, Bhattacharya S. Utilization of Guanidine-Based Ancillary Ligands in Arene-Ruthenium Complexes for Selective Cytotoxicity. ACS Omega 2021;6:8226-38. [PMID: 33817481 DOI: 10.1021/acsomega.0c06265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
105 Jiang W, Fan S, Zhou Q, Zhang F, Kuang D, Tan Y. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties. Bioorg Chem 2020;94:103402. [PMID: 31718891 DOI: 10.1016/j.bioorg.2019.103402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Spisz P, Chylewska A, Królicka A, Ramotowska S, Dąbrowska A, Makowski M. Stimulation of Sulfonamides Antibacterial Drugs Activity as a Result of Complexation with Ru(III): Physicochemical and Biological Study. Int J Mol Sci 2021;22:13482. [PMID: 34948278 DOI: 10.3390/ijms222413482] [Reference Citation Analysis]
107 Lovison D, Allegri L, Baldan F, Ballico M, Damante G, Jandl C, Baratta W. Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells. Dalton Trans 2020;49:8375-88. [PMID: 32520028 DOI: 10.1039/d0dt01390k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
108 Chen S, Yao H, Zhou Q, Tse MK, Gunawan YF, Zhu G. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues. Inorg Chem 2020;59:11676-87. [PMID: 32799457 DOI: 10.1021/acs.inorgchem.0c01541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
109 Prakash P, Kumari N, Gayathiri E, Selvam K, Ragunathan MG, Chandrasekaran M, Al-Dosary MA, Hatamleh AA, Nadda AK, Kumar M. In Vitro and In Silico Toxicological Properties of Natural Antioxidant Therapeutic Agent Azimatetracantha. LAM. Antioxidants (Basel) 2021;10:1307. [PMID: 34439555 DOI: 10.3390/antiox10081307] [Reference Citation Analysis]
110 Murray BS, Dyson PJ. Recent progress in the development of organometallics for the treatment of cancer. Curr Opin Chem Biol 2020;56:28-34. [PMID: 31812831 DOI: 10.1016/j.cbpa.2019.11.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
111 Karmakar S, Chatterjee S, Purkait K, Mukherjee A. A trans-dichloridoplatinum(II) complex of a monodentate nitrogen mustard: Synthesis, stability and cytotoxicity studies. J Inorg Biochem 2020;204:110982. [PMID: 31911365 DOI: 10.1016/j.jinorgbio.2019.110982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
112 Chen Y, Wang Q, Li Z, Liu Z, Zhao Y, Zhang J, Liu M, Wang Z, Li D, Han J. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo. Dalton Trans 2020;49:5192-204. [PMID: 32236281 DOI: 10.1039/d0dt00424c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
113 Miranda VM. Medicinal inorganic chemistry: an updated review on the status of metallodrugs and prominent metallodrug candidates. Reviews in Inorganic Chemistry 2021;0:000010151520200030. [DOI: 10.1515/revic-2020-0030] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
114 Yang J, Fang C, Liu H, Wu M, Tao S, Tan Q, Chen Y, Wang T, Li K, Zhong C, Zhang J. Ternary supramolecular nanocomplexes for superior anticancer efficacy of natural medicines. Nanoscale 2021;13:15085-99. [PMID: 34533154 DOI: 10.1039/d1nr02791c] [Reference Citation Analysis]
115 Muddassir M, Alarifi A, Afzal M. A New Piano-Stool Ruthenium(II) P-Cymene-Based Complex: Crystallographic, Hirshfeld Surface, DFT, and Luminescent Studies. Crystals 2021;11:13. [DOI: 10.3390/cryst11010013] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
116 de Oliveira Neto JG, Filho JGS, Bittar EM, Silva LM, de Sousa FF, Domingos HV, Costa-Lotufo LV, Reis AS, Dos Santos AO. Structural, thermal, electronic, vibrational, magnetic, and cytotoxic properties of chloro(glycinato-N,O)(1,10-phenanthroline-N,N')‑copper(II) trihydrate coordination complex. J Inorg Biochem 2022;226:111658. [PMID: 34781206 DOI: 10.1016/j.jinorgbio.2021.111658] [Reference Citation Analysis]
117 Wang Y, Pigeon P, Li W, Yan J, Dansette PM, Othman M, Mcglinchey MJ, Jaouen G. Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114202] [Reference Citation Analysis]
118 Oliveira KM, Honorato J, Demidoff FC, Schultz MS, Netto CD, Cominetti MR, Correa RS, Batista AA. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug. J Inorg Biochem 2021;214:111289. [PMID: 33137682 DOI: 10.1016/j.jinorgbio.2020.111289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
119 Xie L, Guan R, Rees TW, Chao H. Organelle-targeting metal anticancer agents. Medicinal Chemistry. Elsevier; 2020. pp. 287-337. [DOI: 10.1016/bs.adioch.2019.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
120 Mansour AM, Radacki K, Shehab OR. Role of the ancillary ligand in determining the antimicrobial activity of Pd(II) complexes with N^N^N-tridentate Coligand. Polyhedron 2022. [DOI: 10.1016/j.poly.2022.115857] [Reference Citation Analysis]
121 Shao J, Zhang Q, Wei J, Yuchi Z, Cao P, Li SQ, Wang S, Xu JY, Yang S, Zhang Y, Wei JX, Tian JL. Synthesis, crystal structures, anticancer activities and molecular docking studies of novel thiazolidinone Cu(II) and Fe(III) complexes targeting lysosomes: special emphasis on their binding to DNA/BSA. Dalton Trans 2021;50:13387-98. [PMID: 34473154 DOI: 10.1039/d1dt02180j] [Reference Citation Analysis]
122 Jin S, Guo Y, Guo Z, Wang X. Monofunctional Platinum(II) Anticancer Agents. Pharmaceuticals (Basel) 2021;14:133. [PMID: 33562293 DOI: 10.3390/ph14020133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
123 Balázs B, Tóth Z, Kacsir I, Sipos A, Buglyó P, Somsák L, Bokor É, Kardos G, Bai P. Targeting Multiresistant Gram-Positive Bacteria by Ruthenium, Osmium, Iridium and Rhodium Half-Sandwich Type Complexes With Bidentate Monosaccharide Ligands. Front Chem 2022;10:868234. [DOI: 10.3389/fchem.2022.868234] [Reference Citation Analysis]
124 da Silva MM, Ribeiro GH, de Camargo MS, Ferreira AG, Ribeiro L, Barbosa MIF, Deflon VM, Castelli S, Desideri A, Corrêa RS, Ribeiro AB, Nicolella HD, Ozelin SD, Tavares DC, Batista AA. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo. Inorg Chem 2021;60:14174-89. [PMID: 34477373 DOI: 10.1021/acs.inorgchem.1c01539] [Reference Citation Analysis]
125 Kar B, Roy N, Pete S, Moharana P, Paira P. Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals. Inorganica Chimica Acta 2020;512:119858. [DOI: 10.1016/j.ica.2020.119858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Mondal A, Paira P. Hypoxia efficient and glutathione-resistant cytoselective ruthenium( ii )- p -cymene-arylimidazophenanthroline complexes: biomolecular interaction and live cell imaging. Dalton Trans 2020;49:12865-78. [DOI: 10.1039/d0dt02069a] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
127 Kladnik J, Kljun J, Burmeister H, Ott I, Romero-Canelón I, Turel I. Towards Identification of Essential Structural Elements of Organoruthenium(II)-Pyrithionato Complexes for Anticancer Activity. Chemistry 2019;25:14169-82. [PMID: 31461189 DOI: 10.1002/chem.201903109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
128 Li Y, Yue K, Li L, Niu J, Liu H, Ma J, Xie S. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance. Bioorg Chem 2020;101:104011. [PMID: 32599363 DOI: 10.1016/j.bioorg.2020.104011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Mukherjee A, Acharya S, Purkait K, Chakraborty K, Bhattacharjee A, Mukherjee A. Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex. Inorg Chem 2020;59:6581-94. [PMID: 32295347 DOI: 10.1021/acs.inorgchem.0c00694] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
130 Zhang C, Guan R, Liao X, Ouyang C, Liu J, Ji L, Chao H. Mitochondrial DNA targeting and impairment by a dinuclear Ir–Pt complex that overcomes cisplatin resistance. Inorg Chem Front 2020;7:1864-71. [DOI: 10.1039/d0qi00224k] [Cited by in Crossref: 11] [Article Influence: 5.5] [Reference Citation Analysis]
131 Ravera M, Zanellato I, Gabano E, Perin E, Rangone B, Coppola M, Osella D. Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen . Int J Mol Sci 2019;20:E3074. [PMID: 31238499 DOI: 10.3390/ijms20123074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
132 Shahzad K, Asad M, Asiri AM, Irfan M, Iqbal MA. In-vitro anticancer profile of recent ruthenium complexes against liver cancer. Reviews in Inorganic Chemistry 2022;0. [DOI: 10.1515/revic-2021-0040] [Reference Citation Analysis]
133 Yougbaré S, Mutalik C, Chung PF, Krisnawati DI, Rinawati F, Irawan H, Kristanto H, Kuo TR. Gold Nanorod-Decorated Metallic MoS2 Nanosheets for Synergistic Photothermal and Photodynamic Antibacterial Therapy. Nanomaterials (Basel) 2021;11:3064. [PMID: 34835828 DOI: 10.3390/nano11113064] [Reference Citation Analysis]
134 Yuan S, Chen S, Wu H, Jiang H, Zheng S, Zhang Q, Liu Y. NAMI-A preferentially reacts with the Sp1 protein: understanding the anti-metastasis effect of the drug. Chem Commun 2020;56:1397-400. [DOI: 10.1039/c9cc08775c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
135 Yin H, Gao J, Chen X, Ma B, Yang Z, Tang J, Wang B, Chen T, Wang C, Gao S, Zhang J. A Gallium(III) Complex that Engages Protein Disulfide Isomerase A3 (PDIA3) as an Anticancer Target. Angew Chem Int Ed 2020;59:20147-53. [DOI: 10.1002/anie.202008432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
136 Valente A, Podolski-Renić A, Poetsch I, Filipović N, López Ó, Turel I, Heffeter P. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance. Drug Resist Updat 2021;58:100778. [PMID: 34403910 DOI: 10.1016/j.drup.2021.100778] [Reference Citation Analysis]
137 Sonkar C, Sarkar S, Mukhopadhyay S. Ruthenium( ii )–arene complexes as anti-metastatic agents, and related techniques. RSC Med Chem 2022;13:22-38. [DOI: 10.1039/d1md00220a] [Reference Citation Analysis]
138 Zięba A, Stępnicki P, Matosiuk D, Kaczor AA. What are the challenges with multi-targeted drug design for complex diseases? Expert Opin Drug Discov 2022;:1-11. [PMID: 35549603 DOI: 10.1080/17460441.2022.2072827] [Reference Citation Analysis]
139 Geyl KK, Baykov SV, Kalinin SA, Bunev AS, Troshina MA, Sharonova TV, Skripkin MY, Kasatkina SO, Presnukhina SI, Shetnev AA, Krasavin MY, Boyarskiy VP. Synthesis, Structure, and Antiproliferative Action of 2-Pyridyl Urea-Based Cu(II) Complexes. Biomedicines 2022;10:461. [DOI: 10.3390/biomedicines10020461] [Reference Citation Analysis]
140 Aminzadeh M, Mansouri-Torshizi H, Aleeshah R, Abdi K, Saeidifar M. A new palladium-based antiproliferative agent: synthesis, characterization, computational calculations, cytotoxicity, and DNA binding properties. Biometals 2021. [PMID: 34363565 DOI: 10.1007/s10534-021-00335-8] [Reference Citation Analysis]
141 Wu J, Yang T, Wang X, Li W, Pang M, Sun H, Liang H, Yang F. Development of a multi-target anticancer Sn(ii) pyridine-2-carboxaldehyde thiosemicarbazone complex. Dalton Trans 2021;50:10909-21. [PMID: 34313274 DOI: 10.1039/d1dt01272j] [Reference Citation Analysis]
142 Annunziata A, Amoresano A, Cucciolito ME, Esposito R, Ferraro G, Iacobucci I, Imbimbo P, Lucignano R, Melchiorre M, Monti M, Scognamiglio C, Tuzi A, Monti DM, Merlino A, Ruffo F. Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes. Inorg Chem 2020;59:4002-14. [PMID: 32129608 DOI: 10.1021/acs.inorgchem.9b03683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
143 Kitteringham E, Andriollo E, Gandin V, Montagner D, Griffith DM. Synthesis, characterisation and in vitro antitumour potential of novel Pt(II) estrogen linked complexes. Inorganica Chimica Acta 2019;495:118944. [DOI: 10.1016/j.ica.2019.05.043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
144 Khoury A, Deo KM, Aldrich-Wright JR. Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action. J Inorg Biochem 2020;207:111070. [PMID: 32299045 DOI: 10.1016/j.jinorgbio.2020.111070] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
145 Yougbaré S, Mutalik C, Okoro G, Lin IH, Krisnawati DI, Jazidie A, Nuh M, Chang CC, Kuo TR. Emerging Trends in Nanomaterials for Antibacterial Applications. Int J Nanomedicine 2021;16:5831-67. [PMID: 34475754 DOI: 10.2147/IJN.S328767] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Kitteringham E, Mckeon AM, O'dowd P, Devocelle M, Murphy BM, Griffith DM. Synthesis and characterisation of a novel mono functionalisable Pt(IV) oxaliplatin-type complex and its peptide conjugate. Inorganica Chimica Acta 2020;505:119492. [DOI: 10.1016/j.ica.2020.119492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Guimarães IDL, Marszaukowski F, Ribeiro R, de Lazaro SR, de Oliveira KM, Batista AA, Castellen P, Wrobel E, Garcia JR, Boeré RT, Wohnrath K. Synthesis and characterization of η6-p-cymene ruthenium(II) complexes containing alkyl- and methoxy-substituted triarylphosphines. Journal of Organometallic Chemistry 2021;931:121599. [DOI: 10.1016/j.jorganchem.2020.121599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Florio D, Cuomo M, Iacobucci I, Ferraro G, Mansour AM, Monti M, Merlino A, Marasco D. Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes. Pharmaceuticals (Basel) 2020;13:E171. [PMID: 32751396 DOI: 10.3390/ph13080171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
149 Boros E, Dyson PJ, Gasser G. Classification of Metal-based Drugs According to Their Mechanisms of Action. Chem 2020;6:41-60. [PMID: 32864503 DOI: 10.1016/j.chempr.2019.10.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 20.3] [Reference Citation Analysis]
150 Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood. Dalton Trans 2020;49:8107-13. [PMID: 32490446 DOI: 10.1039/d0dt01297a] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 da Silva AV, Meneghetti SMP, Meneghetti MR. Benzodiazepines: Drugs with Chemical Skeletons Suitable for the Preparation of Metallacycles with Potential Pharmacological Activity. Molecules 2021;26:2796. [PMID: 34068533 DOI: 10.3390/molecules26092796] [Reference Citation Analysis]
152 Ravera M, Gabano E, Mcglinchey MJ, Osella D. A view on multi-action Pt(IV) antitumor prodrugs. Inorganica Chimica Acta 2019;492:32-47. [DOI: 10.1016/j.ica.2019.04.025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 11.3] [Reference Citation Analysis]
153 Jain A, Garrett NT, Malone ZP. Ruthenium-based Photoactive Metalloantibiotics. Photochem Photobiol 2021. [PMID: 33882620 DOI: 10.1111/php.13435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Silva-Caldeira PP, Oliveira Junior ACA, Pereira-Maia EC. Photocytotoxic Activity of Ruthenium(II) Complexes with Phenanthroline-Hydrazone Ligands. Molecules 2021;26:2084. [PMID: 33917290 DOI: 10.3390/molecules26072084] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Teixeira RG, Belisario DC, Fontrodona X, Romero I, Tomaz AI, Garcia MH, Riganti C, Valente A. Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds. Inorg Chem Front 2021;8:1983-96. [DOI: 10.1039/d0qi01344g] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
156 Liu H, Ma J, Li Y, Yue K, Li L, Xi Z, Zhang X, Liu J, Feng K, Ma Q, Liu S, Guo S, Wang PG, Wang C, Xie S. Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents. J Med Chem 2019;62:11324-34. [PMID: 31765154 DOI: 10.1021/acs.jmedchem.9b01641] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
157 Rehm T, Rothemund M, Dietel T, Kempe R, Schobert R. Synthesis, structures and cytotoxic effects in vitro of cis- and trans-[PtIVCl4(NHC)2] complexes and their PtII precursors. Dalton Trans 2019;48:16358-65. [PMID: 31624819 DOI: 10.1039/c9dt02438g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
158 Rivas F, Medeiros A, Quiroga C, Benítez D, Comini M, Rodríguez-Arce E, Machado I, Cerecetto H, Gambino D. New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues. Dalton Trans 2021;50:1651-65. [PMID: 33449983 DOI: 10.1039/d0dt03963b] [Reference Citation Analysis]
159 Contel M. Unconventional Anticancer Metallodrugs and Strategies to Improve Their Pharmacological Profile. Inorganics 2019;7:88. [DOI: 10.3390/inorganics7070088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Shen YH, Esper AM, Ghiviriga I, Abboud KA, Schanze KS, Ehm C, Veige AS. SPAAC iClick: progress towards a bioorthogonal reaction in-corporating metal ions. Dalton Trans 2021;50:12681-91. [PMID: 34545891 DOI: 10.1039/d1dt02626g] [Reference Citation Analysis]
161 Máliková K, Masaryk L, Štarha P. Anticancer Half-Sandwich Rhodium(III) Complexes. Inorganics 2021;9:26. [DOI: 10.3390/inorganics9040026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
162 Chen C, Xu C, Li T, Lu S, Luo F, Wang H. Novel NHC-coordinated ruthenium(II) arene complexes achieve synergistic efficacy as safe and effective anticancer therapeutics. Eur J Med Chem 2020;203:112605. [PMID: 32688202 DOI: 10.1016/j.ejmech.2020.112605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
163 Alberto ME, Mazzone G, Regina C, Russo N, Sicilia E. Theoretical exploration of the photophysical properties of two-component RuII-porphyrin dyes as promising assemblies for a combined antitumor effect. Dalton Trans 2020;49:12653-61. [PMID: 32870211 DOI: 10.1039/d0dt02197k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Demoro B, Bento-Oliveira A, Marques F, Costa Pessoa J, Otero L, Gambino D, F M de Almeida R, Tomaz AI. Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity. Molecules 2019;24:E2861. [PMID: 31394747 DOI: 10.3390/molecules24162861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
165 Li Y, Shi S, Zhang S, Gan Z, Wang X, Zhao X, Zhu Y, Cao M, Wang X, Li W. ctc-[Pt(NH3)2(cinnamate)(valproate)Cl2] is a highly potent and low-toxic triple action anticancer prodrug. Dalton Trans 2021;50:11180-8. [PMID: 34338267 DOI: 10.1039/d1dt01421h] [Reference Citation Analysis]
166 Sudhindra P, Ajay Sharma S, Roy N, Moharana P, Paira P. Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review. Polyhedron 2020;192:114827. [DOI: 10.1016/j.poly.2020.114827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
167 Ferraro MG, Piccolo M, Misso G, Maione F, Montesarchio D, Caraglia M, Paduano L, Santamaria R, Irace C. Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems. Cells 2020;9:E1412. [PMID: 32517101 DOI: 10.3390/cells9061412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
168 Das D, Banaspati A, Das N, Bora B, Raza MK, Goswami TK. Visible light-induced cytotoxicity studies on Co(ii) complexes having an anthracene-based curcuminoid ligand. Dalton Trans 2019;48:12933-42. [PMID: 31393480 DOI: 10.1039/c9dt01576k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
169 Rocco D, Batchelor LK, Ferretti E, Zacchini S, Pampaloni G, Dyson PJ, Marchetti F. Piano Stool Aminoalkylidene‐Ferracyclopentenone Complexes from Bimetallic Precursors: Synthesis and Cytotoxicity Data. ChemPlusChem 2020;85:110-22. [DOI: 10.1002/cplu.201900639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
170 Mármol I, Castellnou P, Alvarez R, Gimeno MC, Rodríguez-Yoldi MJ, Cerrada E. Alkynyl Gold(I) complexes derived from 3-hydroxyflavones as multi-targeted drugs against colon cancer. Eur J Med Chem 2019;183:111661. [PMID: 31546196 DOI: 10.1016/j.ejmech.2019.111661] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
171 Xiong K, Zhou Y, Karges J, Du K, Shen J, Lin M, Wei F, Kou J, Chen Y, Ji L, Chao H. Autophagy-Dependent Apoptosis Induced by Apoferritin-Cu(II) Nanoparticles in Multidrug-Resistant Colon Cancer Cells. ACS Appl Mater Interfaces 2021;13:38959-68. [PMID: 34379404 DOI: 10.1021/acsami.1c07223] [Reference Citation Analysis]
172 Singh K, Jana A, Lippmann P, Ott I, Das N. Isomeric platinum organometallics derived from pyrimidine, pyridazine or pyrazine and their potential as antitumor drugs. Inorganica Chimica Acta 2019;493:112-7. [DOI: 10.1016/j.ica.2019.04.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Bhattacharyya A, Jameei A, Karande AA, Chakravarty AR. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT. Eur J Med Chem 2021;220:113438. [PMID: 33915370 DOI: 10.1016/j.ejmech.2021.113438] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Gandioso A, Rovira A, Shi H, Sadler PJ, Marchán V. Unexpected photoactivation pathways in a folate-receptor-targeted trans-diazido Pt(IV) anticancer pro-drug. Dalton Trans 2020;49:11828-34. [PMID: 32815971 DOI: 10.1039/d0dt02577a] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Ravera M, Gabano E, Perin E, Rangone B, Bonzani D, Osella D. Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? Bioinorg Chem Appl 2021;2021:9489926. [PMID: 34239547 DOI: 10.1155/2021/9489926] [Reference Citation Analysis]
176 Askari B, Amiri Rudbari H, Micale N, Schirmeister T, Efferth T, Seo EJ, Bruno G, Schwickert K. Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies. Dalton Trans 2019;48:15869-87. [PMID: 31620752 DOI: 10.1039/c9dt02353d] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Oliveira BL, Stenton BJ, Unnikrishnan VB, de Almeida CR, Conde J, Negrão M, Schneider FSS, Cordeiro C, Ferreira MG, Caramori GF, Domingos JB, Fior R, Bernardes GJL. Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation. J Am Chem Soc 2020;142:10869-80. [PMID: 32456416 DOI: 10.1021/jacs.0c01622] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 14.5] [Reference Citation Analysis]
178 Seroka B, Łotowski Z, Hryniewicka A, Rárová L, R Sicinski R, M Tomkiel A, W Morzycki J. Synthesis of New Cisplatin Derivatives from Bile Acids. Molecules 2020;25:E655. [PMID: 32033039 DOI: 10.3390/molecules25030655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
179 Kumar P, Swagatika S, Dasari S, Tomar RS, Patra AK. Modulation of ruthenium anticancer drugs analogs with tolfenamic acid: Reactivity, biological interactions and growth inhibition of yeast cell. Journal of Inorganic Biochemistry 2019;199:110769. [DOI: 10.1016/j.jinorgbio.2019.110769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
180 Yufanyi DM, Abbo HS, Titinchi SJ, Neville T. Platinum(II) and Ruthenium(II) complexes in medicine: Antimycobacterial and Anti-HIV activities. Coordination Chemistry Reviews 2020;414:213285. [DOI: 10.1016/j.ccr.2020.213285] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
181 Weng C, Shen L, Teo JW, Lim ZC, Loh BS, Ang WH. Targeted Antibacterial Strategy Based on Reactive Oxygen Species Generated from Dioxygen Reduction Using an Organoruthenium Complex. JACS Au 2021;1:1348-54. [PMID: 34604844 DOI: 10.1021/jacsau.1c00262] [Reference Citation Analysis]
182 Predarska I, Saoud M, Morgan I, Eichhorn T, Kaluđerović GN, Hey-Hawkins E. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line. Dalton Trans 2021. [PMID: 34877948 DOI: 10.1039/d1dt03265h] [Reference Citation Analysis]
183 Acharya S, Maji M, Chakraborty MP, Bhattacharya I, Das R, Gupta A, Mukherjee A. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases. Inorg Chem 2021;60:3418-30. [PMID: 33554592 DOI: 10.1021/acs.inorgchem.0c03820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
184 Ude Z, Kavanagh K, Twamley B, Pour M, Gathergood N, Kellett A, Marmion CJ. A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties. Dalton Trans 2019;48:8578-93. [DOI: 10.1039/c9dt00250b] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
185 Dai Z, Wang Z. Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action. Molecules 2020;25:E5167. [PMID: 33171980 DOI: 10.3390/molecules25215167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
186 Lv W, Cao M, Liu J, Hei Y, Bai J. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia. Acta Biomater 2021;135:617-27. [PMID: 34407474 DOI: 10.1016/j.actbio.2021.08.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Liu Y, Tian H, Xu L, Zhou L, Wang J, Xu B, Liu C, Elding LI, Shi T. Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma. Int J Mol Sci 2019;20:E5660. [PMID: 31726728 DOI: 10.3390/ijms20225660] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
188 Frei A, Ramu S, Lowe GJ, Dinh H, Semenec L, Elliott AG, Zuegg J, Deckers A, Jung N, Bräse S, Cain AK, Blaskovich MAT. Platinum Cyclooctadiene Complexes with Activity against Gram-positive Bacteria. ChemMedChem 2021. [PMID: 34018686 DOI: 10.1002/cmdc.202100157] [Reference Citation Analysis]
189 Li Z, Wang Q, Li L, Chen Y, Cui J, Liu M, Zhang N, Liu Z, Han J, Wang Z. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response. J Med Chem 2021;64:17920-35. [PMID: 34852203 DOI: 10.1021/acs.jmedchem.1c01236] [Reference Citation Analysis]
190 Kaneko M, Kato A, Nakashima S, Kitatsuji Y. Density Functional Theory (DFT)-Based Bonding Analysis Correlates Ligand Field Strength with 99 Ru Mössbauer Parameters of Ruthenium–Nitrosyl Complexes. Inorg Chem 2019;58:14024-33. [DOI: 10.1021/acs.inorgchem.9b02024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
191 Biancalana L, Gruchała M, Batchelor LK, Błauż A, Monti A, Pampaloni G, Rychlik B, Dyson PJ, Marchetti F. Conjugating Biotin to Ruthenium(II) Arene Units via Phosphine Ligand Functionalization. Eur J Inorg Chem 2020;2020:1061-72. [DOI: 10.1002/ejic.201900922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
192 Alessio E, Messori L. NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry. Molecules 2019;24:E1995. [PMID: 31137659 DOI: 10.3390/molecules24101995] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 33.7] [Reference Citation Analysis]
193 Annunziata A, Cucciolito ME, Esposito R, Ferraro G, Monti DM, Merlino A, Ruffo F. Five‐Coordinate Platinum(II) Compounds as Potential Anticancer Agents. Eur J Inorg Chem 2020;2020:918-29. [DOI: 10.1002/ejic.201900771] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
194 Pavlović M, Tadić A, Gligorijević N, Poljarević J, Petrović T, Dojčinović B, Savić A, Radulović S, Grgurić-Šipka S, Aranđelović S. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells. J Inorg Biochem 2020;210:111155. [PMID: 32768729 DOI: 10.1016/j.jinorgbio.2020.111155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
195 Tremlett WD, Tong KK, Steel TR, Movassaghi S, Hanif M, Jamieson SM, Söhnel T, Hartinger CG. Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility. Journal of Inorganic Biochemistry 2019;199:110768. [DOI: 10.1016/j.jinorgbio.2019.110768] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
196 Liu M, Song X, Wu Y, Qian J, Xu J. Cu( ii )-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis. Dalton Trans 2020;49:114-23. [DOI: 10.1039/c9dt03641e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
197 Wang P, Wang JW, Zhang WH, Bai H, Tang G, Young DJ. In Vitro Anticancer Activity of Nanoformulated Mono- and Di-nuclear Pt Compounds. Chem Asian J 2021. [PMID: 34387027 DOI: 10.1002/asia.202100901] [Reference Citation Analysis]
198 Green LPM, Steel TR, Riisom M, Hanif M, Söhnel T, Jamieson SMF, Wright LJ, Crowley JD, Hartinger CG. Synthetic Strategy Towards Heterodimetallic Half-Sandwich Complexes Based on a Symmetric Ditopic Ligand. Front Chem 2021;9:786367. [PMID: 34926406 DOI: 10.3389/fchem.2021.786367] [Reference Citation Analysis]
199 Srivastava P, Shukla M, Kaul G, Chopra S, Patra AK. Rationally designed curcumin based ruthenium(ii) antimicrobials effective against drug-resistant Staphylococcus aureus. Dalton Trans 2019;48:11822-8. [PMID: 31215556 DOI: 10.1039/c9dt01650c] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 5.7] [Reference Citation Analysis]
200 Ariga K. Nanoarchitectonics Revolution and Evolution: From Small Science to Big Technology. Small Science 2021;1:2000032. [DOI: 10.1002/smsc.202000032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
201 Malali S, Chyba J, Knor M, Horní M, Nečas M, Novotný J, Marek R. Zwitterionic Ru(III) Complexes: Stability of Metal-Ligand Bond and Host-Guest Binding with Cucurbit[7]uril. Inorg Chem 2020;59:10185-96. [PMID: 32633504 DOI: 10.1021/acs.inorgchem.0c01328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Ahmedova A, Mihaylova R, Stoykova S, Mihaylova V, Paunova-Krasteva T, Mihaylov L, Stoitsova S, Nihtianova D, Momekov G, Momekova D, Yoshizawa M. Enhanced cellular uptake of platinum by a tetracationic Pt(II) nanocapsule and its implications to cancer treatment. Eur J Pharm Sci 2020;155:105545. [PMID: 32927069 DOI: 10.1016/j.ejps.2020.105545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 Geisler H, Westermayr J, Cseh K, Wenisch D, Fuchs V, Harringer S, Plutzar S, Gajic N, Hejl M, Jakupec MA, Marquetand P, Kandioller W. Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies. Inorg Chem 2021;60:9805-19. [PMID: 34115482 DOI: 10.1021/acs.inorgchem.1c01083] [Reference Citation Analysis]
204 Maji M, Acharya S, Bhattacharya I, Gupta A, Mukherjee A. Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) p -Cymene Complexes. Inorg Chem 2021;60:4744-54. [DOI: 10.1021/acs.inorgchem.0c03706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
205 Wernitznig D, Meier-Menches SM, Cseh K, Theiner S, Wenisch D, Schweikert A, Jakupec MA, Koellensperger G, Wernitznig A, Sommergruber W, Keppler BK. Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids. Metallomics 2020;12:2121-33. [PMID: 33295928 DOI: 10.1039/d0mt00227e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
206 Annunziata A, Cucciolito ME, Esposito R, Imbimbo P, Petruk G, Ferraro G, Pinto V, Tuzi A, Monti DM, Merlino A, Ruffo F. A highly efficient and selective antitumor agent based on a glucoconjugated carbene platinum( ii ) complex. Dalton Trans 2019;48:7794-800. [DOI: 10.1039/c9dt01614g] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
207 Khan TA, Bhar K, Thirumoorthi R, Roy TK, Sharma AK. Design, synthesis, characterization and evaluation of the anticancer activity of water-soluble half-sandwich ruthenium( ii ) arene halido complexes. New J Chem 2020;44:239-57. [DOI: 10.1039/c9nj03663f] [Cited by in Crossref: 10] [Article Influence: 5.0] [Reference Citation Analysis]
208 Chatterjee R, Bhattacharya I, Roy S, Purkait K, Koley TS, Gupta A, Mukherjee A. Synthesis, Characterization, and Cytotoxicity of Morpholine-Containing Ruthenium(II) p-Cymene Complexes. Inorg Chem 2021;60:12172-85. [PMID: 34346215 DOI: 10.1021/acs.inorgchem.1c01363] [Reference Citation Analysis]
209 Xu Z, Wang Z, Deng Z, Zhu G. Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs. Coordination Chemistry Reviews 2021;442:213991. [DOI: 10.1016/j.ccr.2021.213991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
210 Ribeiro GH, Guedes APM, de Oliveira TD, de Correia CRSTB, Colina-Vegas L, Lima MA, Nóbrega JA, Cominetti MR, Rocha FV, Ferreira AG, Castellano EE, Teixeira FR, Batista AA. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction. Inorg Chem 2020;59:15004-18. [PMID: 32997499 DOI: 10.1021/acs.inorgchem.0c01835] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
211 Gibson D. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end? J Inorg Biochem 2021;217:111353. [PMID: 33477089 DOI: 10.1016/j.jinorgbio.2020.111353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
212 Ma J, Li L, Yue K, Li Y, Liu H, Wang PG, Wang C, Wang J, Luo W, Xie S. Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance. Bioorg Chem 2020;99:103768. [PMID: 32217375 DOI: 10.1016/j.bioorg.2020.103768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
213 Michlewska S, Maroto M, Hołota M, Kubczak M, Sanz Del Olmo N, Ortega P, Shcharbin D, de la Mata FJ, Bryszewska M, Ionov M. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells. Dalton Trans 2021;50:9500-11. [PMID: 34254615 DOI: 10.1039/d1dt01388b] [Reference Citation Analysis]
214 Rigamonti L, Reginato F, Ferrari E, Pigani L, Gigli L, Demitri N, Kopel P, Tesarova B, Heger Z. From solid state to in vitro anticancer activity of copper(II) compounds with electronically-modulated NNO Schiff base ligands. Dalton Trans 2020;49:14626-39. [PMID: 33057512 DOI: 10.1039/d0dt03038d] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
215 Huang H, Cao K, Kong Y, Yuan S, Liu H, Wang Y, Liu Y. A dual functional ruthenium arene complex induces differentiation and apoptosis of acute promyelocytic leukemia cells. Chem Sci 2019;10:9721-8. [PMID: 32055340 DOI: 10.1039/c9sc03110c] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
216 Zhang S, Zhong X, Yuan H, Guo Y, Song D, Qi F, Zhu Z, Wang X, Guo Z. Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum( iv ) prodrugs. Chem Sci 2020;11:3829-35. [DOI: 10.1039/d0sc00197j] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
217 Wang Y, Jin J, Shu L, Li T, Lu S, Subarkhan MKM, Chen C, Wang H. New Organometallic Ruthenium(II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer. Chemistry 2020;26:15170-82. [PMID: 32639591 DOI: 10.1002/chem.202002970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Dröge F, Noakes FF, Archer SA, Sreedharan S, Raza A, Robertson CC, MacNeil S, Haycock JW, Carson H, Meijer AJHM, Smythe CGW, Bernardino de la Serna J, Dietzek-Ivanšić B, Thomas JA. A Dinuclear Osmium(II) Complex Near-Infrared Nanoscopy Probe for Nuclear DNA. J Am Chem Soc 2021;143:20442-53. [PMID: 34808044 DOI: 10.1021/jacs.1c10325] [Reference Citation Analysis]
219 Chellan P, Avery VM, Duffy S, Land KM, Tam CC, Kim JH, Cheng LW, Romero-Canelón I, Sadler PJ. Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin. J Inorg Biochem 2021;219:111408. [PMID: 33826972 DOI: 10.1016/j.jinorgbio.2021.111408] [Reference Citation Analysis]
220 Gómez J, Sierra D, Ojeda C, Thavalingam S, Miller R, Guzmán F, Metzler-Nolte N. Solid-phase synthesis and evaluation of linear and cyclic ferrocenoyl/ruthenocenoyl water-soluble hexapeptides as potential antibacterial compounds. J Biol Inorg Chem 2021;26:599-615. [PMID: 34292404 DOI: 10.1007/s00775-021-01877-5] [Reference Citation Analysis]
221 Han X, Sahihi M, Whitfield S, Jimenez I. Tuning excited state of bipyridyl platinum(II) complexes with bio-active flavonolate ligand: Structures, photoreactivity, and DFT calculations. Inorganica Chimica Acta 2020;513:119952. [DOI: 10.1016/j.ica.2020.119952] [Reference Citation Analysis]
222 Maji M, Bhattacharya I, Acharya S, Chakraborty MP, Gupta A, Mukherjee A. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells. Inorg Chem 2021;60:4342-6. [PMID: 33711231 DOI: 10.1021/acs.inorgchem.0c03803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
223 Liu J, Ye W, Xu JP, Wang HT, Li XF, Wang WY, Zhou ZZ. Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells. Eur J Med Chem 2021;224:113700. [PMID: 34311158 DOI: 10.1016/j.ejmech.2021.113700] [Reference Citation Analysis]
224 Babu T, Sarkar A, Karmakar S, Schmidt C, Gibson D. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules. Inorg Chem 2020;59:5182-93. [PMID: 32207294 DOI: 10.1021/acs.inorgchem.0c00445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
225 Jain A. Multifunctional, heterometallic ruthenium-platinum complexes with medicinal applications. Coordination Chemistry Reviews 2019;401:213067. [DOI: 10.1016/j.ccr.2019.213067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]